abstract
- This project will clone SARS CoV-2 COVID-19 genes into our ECU patented vector platform to create a vaccine. Immunogenicity of the vaccine, antibody and T lymphocyte responses will be tested in mice. Future funding will be sought for efficacy studies in animals.